Skip to main content
. 2026 Sep 16;18(18):3008. doi: 10.3390/cancers18183008
BBB Blood–brain barrier
CNN Convolutional Neural Network
CT Computed Tomography
CTV Clinical Target Volume
DSC Dice-Sørensen-Coefficient
FET O-(2)-18F-Fluoroethyl-L-Tyrosine
FLAIR T2-weighted fluid-attenuated inversion recovery (magnetic resonance sequence)
GBM Glioblastoma
GT Ground Truth
HD Hausdorff Distance
MR Magnetic Resonance
MR∩PET MR-Enhancing regions with PET-Uptake overlap
MR-Only MR-Enhancing regions without PET-Uptake overlap
OARs Organs at Risk
PC Prospective Cohort
PET Positron Emission Tomography
PPV Positive Predictive Value
PTV Planning Target Volume
RC Retrospective Cohort
RF Radiomic Features
RT Radiation Therapy
T1wCE Contrast-enhanced T1-weighted (magnetic resonance sequence)
WSRT Wilcoxon signed-rank test